MTHFR and hyperhomocysteinemia: Since then it has been recognized that a genetic variant in the methylenetetrahydrofolate reductase (MTHFR) gene reduces the mother’s ability to properly metabolize folic acid by 40–60%, resulting in homocysteinemia thereby increasing the risk of birth defects despite the consumption of otherwise adequate levels of folic acid.